➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKinsey
Merck
McKesson
Colorcon

Last Updated: September 16, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BESIFLOXACIN HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Besifloxacin Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00347932 ↗ A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis. Completed Bausch & Lomb Incorporated Phase 3 2006-06-01 Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis.
NCT00348348 ↗ A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis Completed Bausch & Lomb Incorporated Phase 3 2006-06-01 This is a study to investigate a novel drug candidate for the treatment of bacterial conjunctivitis.
NCT00407589 ↗ Systemic Pharmacokinetics of BOL-303224-A Completed Bausch & Lomb Incorporated Phase 1 2006-10-01 This is a multi-center, open-label, single dose/multiple dose, pharmacokinetic study in participants with bacterial conjunctivitis. The purpose of this study is to determine the extent of systemic exposure to BOL-303224-A following single and multiple topical administration of BOL-303224-A in participants with suspected bacterial conjunctivitis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Besifloxacin Hydrochloride

Condition Name

Condition Name for Besifloxacin Hydrochloride
Intervention Trials
Bacterial Conjunctivitis 5
Cataract Extraction 2
Acute Bacterial Conjunctivitis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Besifloxacin Hydrochloride
Intervention Trials
Conjunctivitis, Bacterial 8
Conjunctivitis 8
Cataract 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Besifloxacin Hydrochloride

Trials by Country

Trials by Country for Besifloxacin Hydrochloride
Location Trials
United States 14
Mexico 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Besifloxacin Hydrochloride
Location Trials
New York 5
New Jersey 2
Massachusetts 1
Florida 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Besifloxacin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Besifloxacin Hydrochloride
Clinical Trial Phase Trials
Phase 4 3
Phase 3 5
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Besifloxacin Hydrochloride
Clinical Trial Phase Trials
Completed 11
Terminated 3
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Besifloxacin Hydrochloride

Sponsor Name

Sponsor Name for Besifloxacin Hydrochloride
Sponsor Trials
Bausch & Lomb Incorporated 12
Johns Hopkins University 1
McGill University Health Center 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Besifloxacin Hydrochloride
Sponsor Trials
Industry 13
Other 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Boehringer Ingelheim
Express Scripts
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.